Mindset Pharma, Inc. is a pharmaceutical discovery and development company. It utilizes a proprietary platform for discovering novel and patentable psychedelic drug candidates for the treatment of neurological and psychiatric disorders. The company was founded by Abdelmalik Slassi on October 7, 2019 and is headquartered in Toronto, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Mindset Pharma Inc market cap is $54.51M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Mindset Pharma Inc 52 week high is $0.559 as of November 15, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Mindset Pharma Inc 52 week low is $0.1626 as of November 15, 2026.
Mindset Pharma Inc stock price today is $0.5381.
Mindset Pharma Inc stock price yesterday was $0.54.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Mindset Pharma Inc's P/E ratio is -11.47.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Mindset Pharma Inc P/B ratio is -34.3157.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Mindset Pharma Inc 50-day moving average is $0.5259.
